Contact Us

MEETING NEWS

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

Feb 6, 2025

HONG KONG,Jan. 27,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting mono

Best Travel Destinations to Go in 2025's Year of the Snake, Based on Your Chinese Zodiac

Feb 6, 2025

SINGAPORE,Jan. 27,2025-- As the Year of the Snake approaches in 2025,it\'s time to take a leaf from the wisdom of the snake and align your travel plans with the stars. Using the guidance of the Chine

JBS and partners donate 3 million tags to improve livestock traceability in Pará

Feb 6, 2025

Company Unveils Program to Support Farmers in Livestock Tagging DAVOS,Switzerland,Jan. 27,2025-- JBS,in partnership with key stakeholders,has announced the donation of 3 million livestock tags to enha

Hisense TV Shipment Share at 14.06% in 2024, Maintains Top Two Global Position for Three Consecutive Years

Feb 6, 2025

QINGDAO,China,Jan. 26,2025-- Hisense,a leading brand in global consumer electronics and home appliances,has reinforced its dominance in the global TV market achieving an unprecedented three consecutiv

Seeking Investors: First-in-Class Immunotherapeutics for Cancer

Feb 6, 2025

ATLANTA,Jan. 27,2025-- Cambium Oncology is pleased to share that their lead drug candidate,ANT308,recently demonstrated outstanding single-agent efficacy and safety in preclinical studies. The drug i

Vantage Delivers a Stellar Showcase at iFX Expo Dubai 2025

Feb 6, 2025

PORT VILA,Vanuatu,Jan. 27,2025--Vantage Markets made a significant impact at the highly anticipated iFX Expo Dubai 2025,held on 15-16 January at the Dubai World Trade Centre. As an Elite Sponsor,Vant

1 ... 102 103 104 105 106 107 108 ... 354